Sankaranarayanan Murugesan

44PUBLICATIONS
95CO-AUTHORS
Metabolic medicineCheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and designCancer therapy (excl. chemotherapy and radiation therapy)Nutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (44)

|Aug 01, 2026
Bixin and Montelukast Combination Mitigates the Progression of MASLD to Cytokine-Driven Inflammatory Stress in an In Vitro Fluid-Dynamic Model.

|May 28, 2026
Discovery of triazole-tethered glycinate and propanoate derivatives bearing a thiolactone moiety as quorum sensing inhibitors of Pseudomonas aeruginosa: design, synthesis, biological evaluation, and biofilm inhibition.

|Feb 20, 2026
Design, Synthesis and Evaluation of Indole-Based 1,2,3-Triazoles as Potential Quorum Sensing and Biofilm Inhibitors Against Pseudomonas aeruginosa.

Kosana Sai Chaitanya, Tsz Tin Yu, Hrushikesh Chaudhari

|Jan 08, 2026
Vanillin Derivatives in Drug Design: Structure-Activity Relationship (SAR) Hotspots and Synthetic Pathways for Enhanced Pharmacological Activity.

Mustapha Suleiman, Murugesan Sankaranarayanan, Kumitaa Theva Das

|Dec 19, 2025
Targeted Delivery of Thymoquinone-Encapsulated Polyethyleneimine/Poly (Lactic Acid) Nanoparticles Into Breast Cancer Cells.

Jeganpandi Senthamarai Pandi, Parasuraman Pavadai, Ewa Babkiewicz

|Oct 20, 2025
Targeting Stearoyl-CoA Desaturase‑1 (SCD1) by the Drug-Nutraceutical Combination of Montelukast and Bixin in Ameliorating Steatotic NAFLD.

Sonakshi Puri, Shivani Kirad, Shubhashree Dash

Pageof 8

Frequent Collaborators

11 joint publications

Venkata Gowri Chandra Sekhar Kondapalli

11 joint publications

Karan Kumar Banoth

6 joint publications

Faheem

5 joint publications

Perinkulam Ravi Deepa